Results 101 to 110 of about 4,942,192 (218)

Oral Health–Related Quality of Life and Depressive Symptoms in Oral Mucosal Diseases: A Cross‐Sectional Observational Pilot Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives To evaluate the association between oral mucosal diseases, oral health‐related quality of life (OHRQoL), and depressive symptoms, and to explore differences across categories. Materials and Methods In this cross‐sectional observational pilot study, consecutive outpatients with oral mucosal disease were enrolled at the Dental Clinic ...
Domenico Cutecchia   +5 more
wiley   +1 more source

Bullous pemphigoid [PDF]

open access: yes
Bullous pemphigoid is a chronic, subepidermal autoimmune blistering disease characterized by tense blisters on erythematous or normal skin that predominantly affects the older population.
Lim, Yen Loo   +11 more
core   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

open access: yesBJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan   +13 more
wiley   +1 more source

The association between COVID‐19 vaccines and bullous pemphigoid risk: A UK population‐based study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Mikolaj Swiderski   +7 more
wiley   +1 more source

Incidence of P200 pemphigoid: A nationwide study

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1675-1681, October 2026.
The anti‐LAMB4 cell‐based immunoassay is a new serological technique that is far superior to dermal immunoblotting for detecting autoantibodies directed against the P200 protein. This method allows a re‐evaluation of the incidence of P200 pemphigoid, which appears to be considerably more frequent than epidermolysis bullosa acquisita.
Fabienne Jouen   +7 more
wiley   +1 more source

Two cases of childhood linear immunoglobulin A bullous dermatosis following multivisceral transplant: A case report

open access: yesSAGE Open Medical Case Reports
Childhood linear immunoglobulin A bullous dermatosis is a well-recognized autoimmune blistering dermatosis that can be idiopathic, drug-induced, secondary to autoimmune diseases, malignancies, infections, or gastrointestinal diseases including ...
Adam C Yu   +4 more
doaj   +1 more source

Coagulation activation in autoimmune bullous diseases

open access: yesClinical and Experimental Immunology, 2009
SummaryThe main autoimmune blistering skin disorders are pemphigus vulgaris (PV) and bullous pemphigoid (BP). They differ in the inflammatory infiltrate, which is more intense in BP. Inflammation is known to activate coagulation in several disorders. Local and systemic activation of coagulation was evaluated in BP and PV.
A.V. Marzano   +5 more
openaire   +4 more sources

The development of an Excel® spreadsheet to document disease activity in autoimmune bullous disease [PDF]

open access: yes, 2013
We have developed a specialised Excel® spreadsheet which records a panel of clinical variables for patients presenting to specialised bullous clinics at our institution.
Supriya S Venugopal   +2 more
core  

The Etiopathogenesis of Autoimmune Bullous Diseases

open access: yes, 2011
Autoimmune bullous diseases are rare disorders affecting skin and mucous membranes which are mediated by pathogenic autoantibodies against target antigens whose function is adhesion within the epidermis or adhesion of epidermis to dermis.
Aktan, ŞEBNEM
core   +1 more source

Tocilizumab for severe and refractory mucous membrane pemphigoid

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1682-1691, October 2026.
Elevated IL‐6 levels identified in mucous membrane pemphigoid support IL‐6 blockade, with tocilizumab demonstrating clinical benefit in nine patients with severe and refractory mucous membrane pemphigoid. Abstract Background Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease involving mucous membranes with a potentially ...
Billal Tedbirt   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy